Skip to main content
PDEX
NASDAQ Industrial Applications And Services

Pro-Dex FY2026 Net Income Jumps 52% to $13.7M; Cash Position Transforms to $8.2M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$65
Mkt Cap
$197.153M
52W Low
$23.47
52W High
$69.855
52W Position info
177% above low
Off High info
7.0% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

PDEX has more than doubled off its 52-week low of $23.47.

Summary

Fiscal 2026 net income rose 52% to $13.7 million, while cash surged to $8.2 million from $419K. Revenue grew 16% to $77.5 million, though backlog fell to $32.9 million.


Key Events · Earnings and Guidance · PDEX

  • FY2026 Net Income Up 52%

    Net income reached $13.7 million ($4.12 diluted EPS) versus $9.0 million ($2.67) in fiscal 2025, driven by 16% revenue growth to $77.5 million.

  • Cash Position Transformed

    Cash and equivalents grew to $8.2 million from $419K a year earlier, with operating cash flow swinging to positive $7.2 million from negative $1.7 million.

  • Backlog Declines 35%

    Backlog fell to $32.9 million from $50.4 million, which management attributes to timing of customer orders rather than demand deterioration.

  • Customer Concentration Remains High

    The largest customer accounted for 78% of fiscal 2026 sales ($60.7 million), up from 75% in fiscal 2025, with the top three customers representing 92% of revenue.


Analysis · PDEX · Industrial Applications And Services

A 52% jump in net income to $13.7 million, or $4.12 per diluted share, capped a strong fiscal 2026 for Pro-Dex. The gains were powered by a 16% revenue increase to $77.5 million and gross margin expansion from 29% to 31%. The balance sheet strengthened dramatically as well—cash grew from $419K to $8.2 million, and operating cash flow swung from negative $1.7 million to positive $7.2 million. Yet the company remains highly concentrated, with one customer representing 78% of sales, and backlog declined 35% to $32.9 million, which management attributes to timing. The APM acquisition added aerospace and defense exposure but contributed only $719K in revenue during the stub period.

How filings like this one have moved

In the 30 days to Sep 10, 2026, 30% of the 1973 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PDEX was trading at $65.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $197.2M. The 52-week trading range was $23.47 to $69.86. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PDEX - Latest Insights

PDEX
Sep 04, 2026, 12:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $72.45
Real-time Price: $59.99 info
Change: -$12.46 (-17%) info
Market Cap: $192.168M info
PDEX
Sep 03, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $65.00
Real-time Price: $59.99 info
Change: -$5.01 (-8%) info
Market Cap: $192.168M info
PDEX
Sep 03, 2026, 4:10 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $65.00
Real-time Price: $59.99 info
Change: -$5.01 (-8%) info
Market Cap: $192.168M info
PDEX
Jun 26, 2026, 5:59 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $61.47
Real-time Price: $59.99 info
Change: -$1.48 (-2%) info
Market Cap: $192.168M info
PDEX
Apr 30, 2026, 4:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $50.14
Real-time Price: $59.99 info
Change: +$9.85 (+20%) info
Market Cap: $192.168M info